Professor Jin Wang is a PI at Shanghai Public Health Clinical Center, Fudan University, China. Dr. Wang has been working in the fields of cancer and infectious diseases. A major focus of his research is to develop novel early detection biomarkers of human cancers utilizing various state-of-the-art genomic technologies, and he has been able to identify several interesting candidate biomarkers of human pancreatic cancers and liver cancer. Dr. Wang has authored/coauthored 3 patents (U.S. WO Patent WO/2012/030,956; P.R. China Patent NO: 99113481.8) and over 30 SCI publications with a citation rate of over 1000. He has received the prestigious Anne Eastland Spears Fellowship Award in Gastrointestinal Cancer Research from the University of Texas, MD Anderson Cancer Center in the USA, and three independent fellowships from reputed institutions including NIH/NIDDK (USA). His laboratory conducts basic and translational research in the following areas: (1) development of novel early detection biomarkers of human gastrointestinal (GI) cancers and (2) pharmacologic ascorbic acid, all-trans retinoid acid, and ncRNAs for treatment of cancer and infectious diseases.